Logo image of LYB

LYONDELLBASELL INDU-CL A (LYB) Stock Fundamental Analysis

USA - NYSE:LYB - NL0009434992 - Common Stock

42.655 USD
-1.09 (-2.48%)
Last: 11/19/2025, 2:58:31 PM
Fundamental Rating

3

Overall LYB gets a fundamental rating of 3 out of 10. We evaluated LYB against 82 industry peers in the Chemicals industry. Both the profitability and financial health of LYB have multiple concerns. LYB has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year LYB was profitable.
In the past year LYB had a positive cash flow from operations.
LYB had positive earnings in each of the past 5 years.
LYB had a positive operating cash flow in each of the past 5 years.
LYB Yearly Net Income VS EBIT VS OCF VS FCFLYB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

1.2 Ratios

LYB has a Return On Assets of -3.59%. This is in the lower half of the industry: LYB underperforms 67.07% of its industry peers.
LYB has a Return On Equity of -11.44%. This is in the lower half of the industry: LYB underperforms 67.07% of its industry peers.
With a Return On Invested Capital value of 3.64%, LYB perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for LYB is above the industry average of 6.13%.
The 3 year average ROIC (10.69%) for LYB is well above the current ROIC(3.64%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA -3.59%
ROE -11.44%
ROIC 3.64%
ROA(3y)6.72%
ROA(5y)7.89%
ROE(3y)19.31%
ROE(5y)24.61%
ROIC(3y)10.69%
ROIC(5y)11.69%
LYB Yearly ROA, ROE, ROICLYB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

1.3 Margins

In the last couple of years the Profit Margin of LYB has declined.
Looking at the Operating Margin, with a value of 3.65%, LYB is doing worse than 67.07% of the companies in the same industry.
In the last couple of years the Operating Margin of LYB has declined.
LYB's Gross Margin of 9.19% is on the low side compared to the rest of the industry. LYB is outperformed by 82.93% of its industry peers.
In the last couple of years the Gross Margin of LYB has declined.
Industry RankSector Rank
OM 3.65%
PM (TTM) N/A
GM 9.19%
OM growth 3Y-24.61%
OM growth 5Y-10.5%
PM growth 3Y-34.85%
PM growth 5Y-19.21%
GM growth 3Y-15.85%
GM growth 5Y-6.35%
LYB Yearly Profit, Operating, Gross MarginsLYB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so LYB is still creating some value.
The number of shares outstanding for LYB remains at a similar level compared to 1 year ago.
The number of shares outstanding for LYB has been reduced compared to 5 years ago.
LYB has a worse debt/assets ratio than last year.
LYB Yearly Shares OutstandingLYB Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M
LYB Yearly Total Debt VS Total AssetsLYB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

LYB has an Altman-Z score of 1.89. This is not the best score and indicates that LYB is in the grey zone with still only limited risk for bankruptcy at the moment.
LYB has a Altman-Z score (1.89) which is in line with its industry peers.
LYB has a debt to FCF ratio of 16.07. This is a negative value and a sign of low solvency as LYB would need 16.07 years to pay back of all of its debts.
LYB has a Debt to FCF ratio (16.07) which is in line with its industry peers.
A Debt/Equity ratio of 1.02 is on the high side and indicates that LYB has dependencies on debt financing.
With a Debt to Equity ratio value of 1.02, LYB is not doing good in the industry: 64.63% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.02
Debt/FCF 16.07
Altman-Z 1.89
ROIC/WACC0.49
WACC7.46%
LYB Yearly LT Debt VS Equity VS FCFLYB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.3 Liquidity

A Current Ratio of 1.57 indicates that LYB should not have too much problems paying its short term obligations.
With a Current ratio value of 1.57, LYB is not doing good in the industry: 69.51% of the companies in the same industry are doing better.
LYB has a Quick Ratio of 1.57. This is a bad value and indicates that LYB is not financially healthy enough and could expect problems in meeting its short term obligations.
LYB has a worse Quick ratio (0.93) than 68.29% of its industry peers.
Industry RankSector Rank
Current Ratio 1.57
Quick Ratio 0.93
LYB Yearly Current Assets VS Current LiabilitesLYB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2

3. Growth

3.1 Past

LYB shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -61.51%.
The Earnings Per Share has been decreasing by -7.75% on average over the past years.
The Revenue for LYB has decreased by -20.07% in the past year. This is quite bad
The Revenue has been growing slightly by 3.02% on average over the past years.
EPS 1Y (TTM)-61.51%
EPS 3Y-29.4%
EPS 5Y-7.75%
EPS Q2Q%-46.28%
Revenue 1Y (TTM)-20.07%
Revenue growth 3Y-4.43%
Revenue growth 5Y3.02%
Sales Q2Q%-25.14%

3.2 Future

LYB is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 5.03% yearly.
Based on estimates for the next years, LYB will show a decrease in Revenue. The Revenue will decrease by -6.25% on average per year.
EPS Next Y-61.2%
EPS Next 2Y-21.33%
EPS Next 3Y-6.1%
EPS Next 5Y5.03%
Revenue Next Year-25.71%
Revenue Next 2Y-13.82%
Revenue Next 3Y-8.97%
Revenue Next 5Y-6.25%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
LYB Yearly Revenue VS EstimatesLYB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 10B 20B 30B 40B 50B
LYB Yearly EPS VS EstimatesLYB Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 5 10 15

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 15.74 indicates a correct valuation of LYB.
The rest of the industry has a similar Price/Earnings ratio as LYB.
LYB's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 25.46.
A Price/Forward Earnings ratio of 10.77 indicates a reasonable valuation of LYB.
LYB's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. LYB is cheaper than 74.39% of the companies in the same industry.
LYB's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 35.39.
Industry RankSector Rank
PE 15.74
Fwd PE 10.77
LYB Price Earnings VS Forward Price EarningsLYB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of LYB indicates a somewhat cheap valuation: LYB is cheaper than 60.98% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, LYB is valued a bit cheaper than the industry average as 67.07% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 18.59
EV/EBITDA 9.3
LYB Per share dataLYB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80 100

4.3 Compensation for Growth

A cheap valuation may be justified as LYB's earnings are expected to decrease with -6.10% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-21.33%
EPS Next 3Y-6.1%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 12.04%, LYB is a good candidate for dividend investing.
In the last 3 months the price of LYB has falen by -27.42%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
Compared to an average industry Dividend Yield of 4.00, LYB pays a better dividend. On top of this LYB pays more dividend than 97.56% of the companies listed in the same industry.
LYB's Dividend Yield is rather good when compared to the S&P500 average which is at 2.44.
Industry RankSector Rank
Dividend Yield 12.04%

5.2 History

The dividend of LYB has a limited annual growth rate of 5.17%.
LYB has paid a dividend for at least 10 years, which is a reliable track record.
LYB has decreased its dividend recently.
Dividend Growth(5Y)5.17%
Div Incr Years1
Div Non Decr Years1
LYB Yearly Dividends per shareLYB Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6 8

5.3 Sustainability

The earnings of LYB are negative and hence is the payout ratio. LYB will probably not be able to sustain this dividend level.
LYB's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP-144.93%
EPS Next 2Y-21.33%
EPS Next 3Y-6.1%
LYB Yearly Income VS Free CF VS DividendLYB Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

LYONDELLBASELL INDU-CL A

NYSE:LYB (11/19/2025, 2:58:31 PM)

42.655

-1.09 (-2.48%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)10-31 2025-10-31/bmo
Earnings (Next)01-29 2026-01-29/amc
Inst Owners74.62%
Inst Owner Change-6.15%
Ins Owners0.18%
Ins Owner Change0.34%
Market Cap13.72B
Revenue(TTM)32.56B
Net Income(TTM)-1.21B
Analysts63.85
Price Target58.71 (37.64%)
Short Float %7.14%
Short Ratio3.62
Dividend
Industry RankSector Rank
Dividend Yield 12.04%
Yearly Dividend5.31
Dividend Growth(5Y)5.17%
DP-144.93%
Div Incr Years1
Div Non Decr Years1
Ex-Date08-25 2025-08-25 (1.37)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.36%
Min EPS beat(2)-23.45%
Max EPS beat(2)24.17%
EPS beat(4)2
Avg EPS beat(4)-4.8%
Min EPS beat(4)-23.45%
Max EPS beat(4)24.17%
EPS beat(8)4
Avg EPS beat(8)-1.26%
EPS beat(12)8
Avg EPS beat(12)5.26%
EPS beat(16)10
Avg EPS beat(16)2.78%
Revenue beat(2)2
Avg Revenue beat(2)2.02%
Min Revenue beat(2)0.76%
Max Revenue beat(2)3.27%
Revenue beat(4)4
Avg Revenue beat(4)1.93%
Min Revenue beat(4)0.76%
Max Revenue beat(4)3.27%
Revenue beat(8)6
Avg Revenue beat(8)0.64%
Revenue beat(12)7
Avg Revenue beat(12)-0.64%
Revenue beat(16)10
Avg Revenue beat(16)0.42%
PT rev (1m)-4.07%
PT rev (3m)-13.41%
EPS NQ rev (1m)-3.65%
EPS NQ rev (3m)-15.51%
EPS NY rev (1m)-1.8%
EPS NY rev (3m)-26.15%
Revenue NQ rev (1m)-3.17%
Revenue NQ rev (3m)-3.57%
Revenue NY rev (1m)-0.33%
Revenue NY rev (3m)-1.53%
Valuation
Industry RankSector Rank
PE 15.74
Fwd PE 10.77
P/S 0.42
P/FCF 18.59
P/OCF 5.14
P/B 1.29
P/tB 1.45
EV/EBITDA 9.3
EPS(TTM)2.71
EY6.35%
EPS(NY)3.96
Fwd EY9.29%
FCF(TTM)2.29
FCFY5.38%
OCF(TTM)8.3
OCFY19.46%
SpS101.22
BVpS32.95
TBVpS29.34
PEG (NY)N/A
PEG (5Y)N/A
Graham Number44.82
Profitability
Industry RankSector Rank
ROA -3.59%
ROE -11.44%
ROCE 4.41%
ROIC 3.64%
ROICexc 3.89%
ROICexgc 4.08%
OM 3.65%
PM (TTM) N/A
GM 9.19%
FCFM 2.27%
ROA(3y)6.72%
ROA(5y)7.89%
ROE(3y)19.31%
ROE(5y)24.61%
ROIC(3y)10.69%
ROIC(5y)11.69%
ROICexc(3y)11.83%
ROICexc(5y)12.68%
ROICexgc(3y)12.95%
ROICexgc(5y)13.92%
ROCE(3y)12.98%
ROCE(5y)14.24%
ROICexgc growth 3Y-25.81%
ROICexgc growth 5Y-9.22%
ROICexc growth 3Y-25.6%
ROICexc growth 5Y-8.64%
OM growth 3Y-24.61%
OM growth 5Y-10.5%
PM growth 3Y-34.85%
PM growth 5Y-19.21%
GM growth 3Y-15.85%
GM growth 5Y-6.35%
F-Score3
Asset Turnover0.96
Health
Industry RankSector Rank
Debt/Equity 1.02
Debt/FCF 16.07
Debt/EBITDA 4.18
Cap/Depr 138.59%
Cap/Sales 5.93%
Interest Coverage 250
Cash Conversion 103.45%
Profit Quality N/A
Current Ratio 1.57
Quick Ratio 0.93
Altman-Z 1.89
F-Score3
WACC7.46%
ROIC/WACC0.49
Cap/Depr(3y)123.27%
Cap/Depr(5y)130.2%
Cap/Sales(3y)4.01%
Cap/Sales(5y)4.66%
Profit Quality(3y)139.02%
Profit Quality(5y)124.38%
High Growth Momentum
Growth
EPS 1Y (TTM)-61.51%
EPS 3Y-29.4%
EPS 5Y-7.75%
EPS Q2Q%-46.28%
EPS Next Y-61.2%
EPS Next 2Y-21.33%
EPS Next 3Y-6.1%
EPS Next 5Y5.03%
Revenue 1Y (TTM)-20.07%
Revenue growth 3Y-4.43%
Revenue growth 5Y3.02%
Sales Q2Q%-25.14%
Revenue Next Year-25.71%
Revenue Next 2Y-13.82%
Revenue Next 3Y-8.97%
Revenue Next 5Y-6.25%
EBIT growth 1Y-60.92%
EBIT growth 3Y-27.96%
EBIT growth 5Y-7.79%
EBIT Next Year-5.52%
EBIT Next 3Y10.46%
EBIT Next 5Y10.29%
FCF growth 1Y-79.05%
FCF growth 3Y-29.85%
FCF growth 5Y-2.67%
OCF growth 1Y-47.04%
OCF growth 3Y-20.83%
OCF growth 5Y-5.1%

LYONDELLBASELL INDU-CL A / LYB FAQ

Can you provide the ChartMill fundamental rating for LYONDELLBASELL INDU-CL A?

ChartMill assigns a fundamental rating of 3 / 10 to LYB.


What is the valuation status for LYB stock?

ChartMill assigns a valuation rating of 5 / 10 to LYONDELLBASELL INDU-CL A (LYB). This can be considered as Fairly Valued.


How profitable is LYONDELLBASELL INDU-CL A (LYB) stock?

LYONDELLBASELL INDU-CL A (LYB) has a profitability rating of 3 / 10.


What are the PE and PB ratios of LYONDELLBASELL INDU-CL A (LYB) stock?

The Price/Earnings (PE) ratio for LYONDELLBASELL INDU-CL A (LYB) is 15.74 and the Price/Book (PB) ratio is 1.29.


How sustainable is the dividend of LYONDELLBASELL INDU-CL A (LYB) stock?

The dividend rating of LYONDELLBASELL INDU-CL A (LYB) is 5 / 10 and the dividend payout ratio is -144.93%.